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ABSTRACT 
 
 Purpose: The purpose of this investigation was to determine the 
volumetric and cross-sectional changes that may occur within the posterior 
pharyngeal airway space after positioning the mandibular condyles in centric 
relation.  
 Materials and Methods: All subjects evaluated presented signs and 
symptoms of upper airway obstruction with significant CR-CO discrepancies. 
Stabilization maxillary splint therapy was employed to seat mandibular condyles 
in CR. Pre- and post-treatment CBCT scans were taken to compare airway 
changes. Thirty-one subjects (13 male and 18 female) with a mean age of 45.8 
years at the time of the post-treatment scan were evaluated. DICOM files were 
interpreted using Anatomage Invivo5 viewing software version. Airway 
measurements included total volume, nasopharynx volume, oropharynx volume, 
minimum cross-sectional area, and cross-sectional area at PNS, CV2, and CV3. 
The location of the minimum cross-sectional area was recorded in reference to 
the superior, middle, and interior thirds of the bodies of CV2 and CV3, and also 
the occlusal plane. A paired two-sample for means T-test was performed to 
determine the significance of change in volume and cross-sectional area. F-test 
was performed to determine the variability for gender with all measurements.   
 Results: Pre-treatment total mean volume was 11.92 cm3 and post-
treatment total mean volume was 12.45 cm3, a mean difference of 0.53 cm3. 
Thirteen out of thirty-one subjects (42%) showed a decrease in total volume, 
whereas eighteen out of thirty-one (58%) exhibited an increase in total volume. 
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The mean increase in total volume was not statistically significant (p=0.22). Pre-
treatment means for cross-sectional area measurements at PNS, CV2, and CV3 
were 466.1, 202.3, and 226.3 mm2, respectively.  Post-treatment mean 
measurements at PNS, CV2 and CV3 were 474.9, 185.4 and 232.1 mm2, 
respectively.  The mean differences between these pre-and post- measurements 
for PNS, CV2, and CV3 are 8.77, -16.89, and 5.82 mm2. These mean differences 
were not statistically significant (p=0.31, p=0.13, and p=0.34). Pre-treatment 
minimum cross-sectional area mean was 115.6 mm2 and post-treatment mean 
was 105.5 mm2. The mean difference was a -10.1 mm2, though this difference 
was not statistically significant (p=0.23).  Differences between pre- and post-
treatment minimum cross-sectional area locations were found on fourteen of the 
thirty-one patients (45%). Twenty-six of the thirty-one subjects (84%) displayed a 
minimum cross-sectional area located at either the superior, middle, or inferior 
third of the CV2 body. In addition, the minimum cross-sectional area was found 
to be inferior to the occlusal plane in twenty-eight of the thirty-one subjects 
(90%). 
 Conclusion: Positioning the mandibular condyles in centric relation does 
influence posterior pharyngeal airway volume and cross-sectional area; however, 
the dimensional changes are not statistically significant. Post-treatment mean 
total volume, oropharynx volume, and nasopharynx volume increased. Mean 
cross-sectional area at PNS and CV3 increased, while mean cross-sectional 
area at CV2 and minimum cross-sectional area decreased. Further studies are 
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needed to assess the clinical efficacy of splint therapy to reduce severity and 
complications that arise from OSA.    
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CHAPTER 1: INTRODUCTION 
  
         Sleep-disordered breathing (SDB) is a spectrum of conditions or diseases 
with abnormal respiratory patterns, resulting in decreased oxyhemoglobin 
saturation during sleep. Obstructive sleep apnea (OSA) is characterized by upper 
airway obstruction resulting in intermittent hypoxia during sleep in affected 
individuals. Complications can range from excessive daytime sleepiness and 
snoring to a variety of cardiovascular diseases including hypertension and heart 
failure (Coughlin S, et al., 2004). 
Over the past two decades public health awareness of OSA and other 
sleep disorders have increased markedly. Epidemiological studies estimate that 
18 million Americans are diagnosed with obstructive sleep apnea; and another 
16 million remain undiagnosed. Once considered a disease that exclusively 
targeted middle-age adults, OSA is now evident in all age groups. Pediatric and 
adolescent victims are trending upward in prevalence. One study found a 
prevalence rate of 2-4% in the middle-aged adult population and 2-3% of children 
in North America (Young T, et al., 2008). Polysomnography has shown to be an 
effective and objective method to diagnose the prevalence and severity of sleep 
apnea.  This test measures the apnea-hypopnea index (AHI) which quantifies the 
number of apneic or hypopneic episodes during sleep.   
The management of OSA patients requires an interdisciplinary approach. 
Both surgical and non-surgical treatment options are available with the goal of 
improving airway patency and airflow. Continuous positive airway pressure 
(CPAP) works as a pneumatic stent and provides positive air pressure through a 
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nasal mask during sleep and has proven to be an effective method of treating 
severe OSA. The efficacy of CPAP therapy largely depends upon patient 
compliance, which has historically been very low. A proven alternative to CPAP 
treatment is oral appliance therapy that positions the mandible in a protruded 
position.  These devices are designed not to cure OSA, but instead to maintain 
the airway open for adequate ventilation during sleep. Several studies have 
shown that oral appliance therapy effectively reduces common medical 
complications of OSA (Imran H, et al., 2013). Unfortunately significant 
advancement of the mandible often results in unwanted dentoalveolar effects, 
particularly when used over long periods of time. Several studies have 
documented these adverse effects to include proclination of mandibular incisors, 
retroclination of maxillary incisors, molar extrusion, and an anteroposterior 
change in molar relationship (Almeida FR, et al., 2006). 
An alternative method of treatment for OSA is the use of splint therapy to 
fully seat the mandibular condyles in centric relation (CR) thereby positioning the 
mandible and nearby soft tissues and muscles of mastication in a physiologic 
and musculoskeletal stable position. This method is utilized in patients diagnosed 
with moderate obstructive sleep apnea who present with significant centric 
relation-centric occlusion (CO) discrepancies.  
Centric relation is most commonly defined as the relationship of the 
mandible to the maxilla when the condyles are seated in their most superior-
anterior position against the posterior slopes of the articular eminences. It is 
widely accepted among authors and clinicians that optimal functional occlusion 
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occurs when there is even and simultaneous contact of posterior teeth with 
condyles positioned in centric relation. This allows the joint and related structures 
to withstand maximum masticatory forces while placing the condyles in an 
orthopedic and musculoskeletal stable position (Okeson JP, 2015).   
Several epidemiological studies have concluded that a large portion of the 
population presents with a small discrepancy between the centric occlusal 
position and the mandible in centric relation (Rider CE, 1978). However, the 
normal ranges for occlusal and condylar displacement in an asymptomatic 
population remains a controversial topic. In patients with significant CR-CO 
discrepancies, there is often a premature anterior/posterior contact with a 
resultant slide into CO upon maximum closure.   
Splint therapy is most commonly utilized for treatment of 
temporomandibular joint disorder (TMD) and para-functional habits including 
nocturnal bruxism and clenching. Stabilization splint therapy is a common 
treatment that has proven effective in deprogramming masticatory muscles and 
stabilizing the temporomandibular joint in centric relation (Clark GT, 1984).  
Identifying the relationship between centric relation and its influence on 
airway space has not previously been studied. Some clinicians have reported 
success treating mild OSA patients who present with significant CR-CO 
discrepancies with stabilization splint therapy. The purpose of this study is to 
determine the changes that may occur within the posterior pharyngeal airway 
space after positioning the mandibular condyles in centric relation.  
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CHAPTER 2: LITERATURE REVIEW 
  
2.1 Sleep Disordered Breathing 
 
         Sleep disordered breathing (SDB) comprises a wide spectrum of sleep-
related breathing abnormalities. These abnormalities include snoring, apneas, 
hypopneas, and respiratory effort-related arousals. SDB is often regarded as a 
spectrum of diseases which can range in severity. Contributory factors that 
determine the prevalence and severity include upper airway skeletal and soft 
tissue dimensions, body mass, age, and gender (Schwab, 1998). 
         SDB consists of three distinct clinical patterns (Young, 1993). Obstructive 
sleep apnea (OSA) occurs when airflow is impeded due to partial or full blockage 
of the upper airway passages, but respiratory effort is present. Central sleep 
apnea is caused by a disruption in the central neuromuscular mechanisms and 
occurs when both airflow and respiratory effort are absent. Mixed apnea occurs 
when characteristics of both obstructive and central sleep apnea are present. 
Obstructive sleep apnea accounts for more than 85% of sleep disordered 
breathing (Ho, 2011). 
         Upper airway resistance syndrome (UARS) is another sleep disorder 
characterized by airway resistance to breathing during sleep, but without any 
diagnosable apnea or hypopnea events. Clinical presentation of UARS can be 
similar to other sleep related disorders, in particular excessive daytime 
sleepiness and snoring. 
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2.2 Obstructive Sleep Apnea 
 
         Obstructive sleep apnea (OSA) is a highly prevalent condition 
characterized by repetitive upper airway obstruction resulting in intermittent 
hypoxia during sleep in affected individuals. These episodes are associated with 
recurrent oxyhemoglobin desaturation and arousals from sleep. OSA was once 
considered a disease that exclusively targeted middle-age adults; however, it is 
now evident that individuals of any age can be affected. One study estimated that 
1 in 5 adults have mild obstructive sleep apnea, while 1 in 15 has moderate sleep 
apnea (Young, 1997). According to the U.S. Department of Health, 12 to 18 
million adults are affected by sleep apnea while many more go undiagnosed. 
One prospective sleep study of 1023 infants found that obstructive and mixed 
apneas are rare in healthy infants (Kato, 2000). Predisposing factors of OSA 
include male gender, increased neck size, retrognathic mandible, increased 
body-mass index, increased age, and narrow airway dimensions (Abad, et al., 
2009).  Recent studies show that the current male-to-female ratio is 
approximately 2 to 3:1 (Davidson, 2005). 
2.2.1 Diagnosis of OSA 
 
         Polysomnography is considered to be the gold standard for diagnosing 
sleep related breathing disorders. During this sleep test, approximately 20 
sensors are attached to the patient, along with a pulse oximeter. Certain 
physiological parameters are recorded, including heart rate, respiratory effort, 
airflow, oxygen saturation, electrical current in the brain, resting potential of the 
6 
 
retina, and electrical currents associated with muscular action and cardiac cycle. 
Often a “split-night study” is utilized, where the patient is monitored for sleep 
related disorders during the first half of the night, and therapy is initiated and 
tested during the second half. 
         The apnea-hypopnea index (AHI) is commonly used to determine the 
severity of obstructive sleep apnea. The index represents the number of apnea 
and hypopnea events per hour of sleep. It is calculated by dividing the number of 
apnea or hypopnea events by the number of hours of sleep. The term “apnea” is 
defined as a cessation of airflow for at least 10 seconds or more. Partial 
obstruction can result in “hypopneas” and are defined as abnormal respiratory 
events that last for at least 10 seconds, have 30% reduction in airflow and cause 
4% or more oxygen desaturation (Young, 1993). AHI values are used to 
determine the severity of OSA. Mild OSA is described as an AHI between 5 and 
15, moderate OSA represents an AHI between 15 and 29, and severe OSA is 
identified with an AHI of 30 or greater (Ruehland WR, et al., 2009). 
         The respiratory disturbance index (RDI) is another formula used to 
interpret polysomnography findings. This index measures respiratory event 
related arousals (RERAs) and also the apnea/hypopnea episodes. RERAs 
indicate arousals from sleep but do not meet the definition of apnea or hypopnea 
episode. Often, these arousals from sleep are transitions from a deeper stage to 
more shallow stage of sleep (Richardson MA, 2007). Some studies have shown 
that RDI may be a more accurate indicator for OSA than the apnea-hypopnea 
index (Ho, ML, 2011). 
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         A variety of subjective screening tests are also utilized to assess daytime 
sleepiness. The Epworth Sleepiness Scale (ESS) is widely used in the field of 
sleep medicine to measure the severity of excessive daytime sleepiness. During 
this self-evaluation test, the subjects rate themselves on a scale of 0 to 3 on how 
likely they are to fall asleep during different normal daytime activities. The greater 
the number, the higher the likelihood of the subject falling asleep. These scores 
are added to obtain a single number which indicates the severity of excessive 
daytime sleepiness. This assessment was first introduced by Dr. Murray Johns of 
Epworth Hospital in Melbourne, Australia (Johns, MW, 1991). Studies have 
validated the success of ESS to accurately detect obstructive sleep apnea, 
narcolepsy and idiopathic hypersomnia, and evaluate treatment outcomes for 
CPAP therapy (Hardinge FM, et al., 1995). 
2.2.2 Complications of OSA 
 
         Several studies indicate a relationship between OSA and a variety of 
cardiovascular diseases, including hypertension, myocardial infarction, stroke 
heart failure, diabetes, and metabolic syndrome (Coughlin S, et al., 2004). One 
recent prospective study showed a strong association between hypertension and 
OSA, with a prevalence rate of 40% (Peppard P, et al., 2000). Patients with 
severe OSA, represented by a high AHI score, correlated with a higher systolic 
and diastolic blood pressure, even after adjustment for confounding factors such 
as age, gender and body mass index (BMI). Data from the Wisconsin Sleep 
Cohort Study provides longitudinal evidence for a causal relationship between 
OSA and hypertension (Peppard P, et al., 2000). 
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         In addition to cardiovascular complications, patients with OSA can 
experience severe sleep deprivation which can lead to decreased physical 
activity, excessive daytime sleepiness, morning headaches and depression. 
Sleep deprivation may also impair carbohydrate metabolism and endocrine 
functions, contributing to weight gain and insulin resistance (Vgontzas A, et al., 
2003). 
2.2.3 Treatment of OSA 
 
         The management of OSA patients requires an interdisciplinary approach 
for both diagnosis and treatment. Comprehensive treatment may include 
correction of any craniofacial deformity that contributes to decreased airway 
dimensions. Both surgical and non-surgical methods are employed to improve 
ventilation by airway volume expansion and reduce collapsibility of soft tissues 
surrounding the airway, including the soft palate and tongue (Riley RW, et al., 
1993).  Non-invasive treatment protocols are recommended initially to improve 
the safety and comfort of the patient. 
2.2.4 Non-Surgical Treatment of OSA 
 
         Non-surgical treatment typically begins with a variety of behavioral 
changes that encourage weight-loss, abstaining from alcohol, smoking or 
changes in sleeping position (Barrera JE, et al., 2007). Both obesity and OSA are 
associated with cardiopulmonary complications. Obese patients with 
cardiovascular risks are amplified in the presence of OSA. One study concluded 
that patients diagnosed with resistant hypertension show a higher prevalence 
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and severity of OSA due to the association of risk factors that are common to 
both conditions (Min HJ, et al., 2015). Weight loss has repeatedly shown to 
decrease the prevalence of OSA. One study of 690 patients showed a 10% 
weight gain led to a 32% worsening in RDI and a 10% weight loss led to a 26% 
improvement (Horner R, et al., 1989).  Other studies have confirmed that weight 
loss can improve SDB (Mortimore I, et al., 1998). 
         Continuous positive airway pressure (CPAP) is currently the gold standard 
for non-surgical treatment of OSA. CPAP works as a pneumatic stent, providing 
a positive air pressure through a nasal mask and effectively preventing the 
collapse of the pharyngeal airway. Convincing data from numerous randomized 
controlled trials in OSA patients with hypertension or heart failure have 
demonstrated that treatment with CPAP not only reduces the risk of developing 
cardiovascular disorders but also disease severity (Mills et al, 2006; Kaneko Y, et 
al., 2003). However, the efficacy of CPAP largely depends upon patient 
compliance. Due to physical discomfort, drying of the nasal and oral mucosal 
membranes, dislodgement during sleep, noise, and social consequences patient 
compliance can be as low as 40% (Goodday RH, et al., 2006). 
         An effective alternative to CPAP treatment is oral appliance therapy. Two 
common oral appliance therapies include mandibular advancement devices 
(MADs) and the tongue retainer devices (TRD). MADs position the mandible in a 
protruded position, creating an anterior movement of the soft tissues and 
muscles surrounding the posterior pharyngeal airway, resulting in improved 
airway patency. Typically the mandible is advanced 50% to 70% of the maximum 
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protrusion. TRDs function by creating suction within the device to hold the tongue 
in a superoanterior position, preventing collapse into the airway during sleep in 
the supine position. These devices are not designed to cure OSA, but instead to 
maintain the airway open for adequate ventilation during sleep. Advantages of 
oral appliances include their small size, ease of adjustability, custom fabrication, 
and ease of use. These advantages have led to high levels of compliance.  
Yoshida found the compliance rate for mandibular advancement devices was 
nearly 90% after a 2.5 year period (Yoshida K, 2000).  When placed in the 
mouth, the MAD will rest on the maxillary and mandibular dentitions. Some 
MAD’s can be self-adjusted to increase or decrease mandibular advancement. 
This feature allows clinicians to perform a titration polysomnogram, where the 
mandible is advanced until apneas and hypopneas are eliminated or maximum 
tolerable advancement is reached. An example of a mandibular advancement 
device is shown in figure 2.1.  
         The American Academy of Sleep Medicine recommends oral appliance 
therapy for patients with mild to moderate OSA, and also for patients with severe 
OSA but are non-compliant with CPAP treatment (Kushida CA, et al., 2006). 
Numerous studies have confirmed the efficacy of oral appliance therapy to 
reduce severity and complications that arise from OSA. A meta-analysis of 
several randomized controlled trials found that oral appliance therapy is 
associated with significant blood pressure reduction in mild to moderate OSA 
patients (Imran H, et al., 2013). Another study of over 250 subjects found a 66% 
reduction in the mean AHI, with oxygen saturation, duration of apnea, sleep 
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efficiency and total arousals significantly improved (Yoshida K, 2000).  In a study 
that compared the short-term clinical efficacy between mandibular advancement 
devices vs CPAP, the authors concluded that in adults with moderate to severe 
OSA, the use of an adjustable MAD was not inferior to CPAP in its impact on 
blood pressure, daytime sleepiness and general quality of life (White DP, et al., 
2013). 
 Until recently, most randomized controlled trial studies were performed 
using 2D cephalometric radiographs. Cossellu performed a three-dimensional 
upper airway evaluation during oral appliance therapy. Nine out of ten subjects 
showed an overall improvement in the apnea-hypopnea index, with an increase 
in volume in both the posterior soft palate and posterior tongue regions (Cossellu 
G, et al., 2015). Another study with a larger sample size of 25 investigated the 
treatment effects of crossbow appliance (Great Lakes Orthodontics, Tonawanda, 
NY) on the upper airway dimensions and volume using cone beam computed 
tomography (CBCT). In addition to favorable class II correction, three-
dimensional evaluation of the upper airway showed an increase in both 
dimension and volume. This study showed no changes in the nasopharyngeal 
region (Erbas B, et al., 2014).   
         There are potential risks with the use of mandibular advancers, especially 
when used long-term. Significant mandibular advancement, particular when 
using the dentition as anchorage, can result in adverse effects on the 
dentoalevolar structures. Almeida et al., found that after 5 years of oral appliance 
use, cephalometric measurements showed proclination of mandibular incisors, 
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maxillary incisor retroclination, molar extrusion, rotation of the mandible, and 
increase in the interincisal angle and lower facial height. Also there was an 
anteroposterior change in the molar relationship, indicating a more forward 
position of the mandibular arch (Almeida FR, et al., 2006). It is believed that 
these movements are a result of repositioning of the mandible forward, and the 
ensuing forces placed on the dentoalevolar structures. Almeida et al., findings 
were confirmed in several other studies. In an observation period of over 11 
years, one study found a significant reduction in overbite, overjet, and mandibular 
crowding, along with incidences of anterior and posterior crossbite. These 
changes in occlusion were progressive in nature, indicating that the dental side 
effects continued to worsen with ongoing oral appliance use (Pliska BT, et al., 
2014). While long-term use is associated with permanent occlusal changes, most 
studies agree that oral appliance therapy does not affect temporomandibular 
disorder prevalence (Martinez J, et al., 2010). One study concluded that patients 
with pre-existing signs and symptoms of TMD that are treated with MADs do not 
experience an exacerbation of those signs and symptoms. In fact, in many 
instances they decreased over time (Perez C, et al., 2011).     
2.2.5 Surgical Treatment of OSA 
 
         Due to the low compliance rate of CPAP therapy with patients suffering 
from moderate to severe sleep apnea, surgical treatment is occasionally 
necessary. There are many surgical options depending on the specific location of 
airway obstruction. Surgical treatment is often classified as either phase I or 
phase II treatment. Phase I treatment may include any one or combination of the 
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following surgeries: septoplasty, adenoidectomy, tonsillectomy, turbinate 
reduction, uvulopalatopharyngoplasy (UPPP), genioglossus advancement, or 
hyoid suspension. Nasal septal and adenoid surgeries are performed to open the 
airway passage in the nasal cavity. Enlarged tonsils or adenoids may interfere 
with airway flow, especially in children. When an enlarged uvula is the site of 
obstruction, a UPPP procedure is performed to partially remove the uvula, 
making the soft palate shorter and firmer. Both genioglossus advancement and 
hyoid suspension are performed to advance the position of the tongue, 
increasing the airway passage (Abad VC, et al., 2009). 
         Phase II surgery is reserved for patients who were unsuccessfully treated 
in phase I. Orthognathic surgery is categorized as phase II surgery, and 
maxillomandibular advancement (MMA) surgery is the most common. The goal 
of MMA is to enlarge the airway passage by displacing the soft tissues, 
musculature, and hard tissues in an anterior and lateral direction. Certain 
patients with craniofacial abnormalities have a predisposition for a collapsed 
airway, and are recommended for immediate phase II surgery. Several studies 
have confirmed the efficacy of MMA to treat moderate to severe obstructive sleep 
apnea. In a retrospective study of 265 patients who underwent MMA surgery for 
treatment of OSA, Goodday found a significant reduction in post mean AHI score 
(Goodday RH, et al., 2015). 
2.3 Centric Relation 
 
         The definition of centric relation (CR) has evolved over the past century 
and is often a topic of controversy. Up until the early 1980’s most clinicians 
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considered CR as the most retruded position of the mandibular condyle within 
the glenoid fossa. The concept of positioning the mandible in the most retruded 
position predominated until more sophisticated temporomandibular joint (TMJ) 
imaging became available. These images led to a change in the definition of CR 
from a posterior-superior to an anterior-superior position (Rinchuse DJ, et al., 
2006). Dawson argued that positioning the condyle distally can cause anterior 
and medial displacement of the TMJ disc (Dawson PE, 1985). The posterior 
portion of the TMJ is composed of retrodiscal tissues and lamina which are highly 
vascularized and well supplied with sensory nerve fibers and posterior 
attachments to the articular disc. These structures are not anatomically 
structured to withstand masticatory forces.  When condyles are displaced in a 
superior-posterior position these tissues can be compressed, eliciting pain and 
potential damage to the retrodiscal structures (Isberg A, et al., 1986).  Currently, 
a widely accepted definition of CR can be described as the relationship of the 
mandible to the maxilla when the condyles are seated against the “thinnest 
avascular portion of the articular disc in their most superior-anterior position 
against the superoposterior slopes of the articular eminences and centered 
transversely, independent of tooth contact” (Howat AP, et al., 1991).   
2.3.1 Musculoskeletal Stability 
 
The TMJ is a bilateral synovial articulation between the mandible and 
temporal bone. Interposed between the condyle and articular eminence is the 
articular disc, which is composed of dense fibrous connective tissue to withstand 
heavy forces and stabilize the condyle during functional movements. However, 
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the articular disc does not determine the positional stability of the TMJ.  Like 
other synovial joints, the stable position is determined by the directional forces of 
the muscles that are applied on the joint rather than the ligaments. Without 
influence from the occlusion, the TMJ is stabilized by the tonus of the masseter, 
medial and lateral pterygoid, and temporalis muscles. The temporalis muscle 
positions the condyle superiorly. The masseter and medial pterygoid muscles 
position the condyle superiorly and anteriorly. And the inferior lateral pterygoid 
muscle positions the condyle anteriorly against the posterior slopes of the 
articular eminence. The action of these directional forces are shown in figure 2.2. 
Therefore, the most stable position of the TMJ is when the condyles are in the 
superior-anterior position against the posterior slope of the articular eminence. 
Okeson described this as the most orthopedically and musculoskeletally stable 
position of the mandible (Okeson JP, 2015).   
Other studies have shown how the action of a healthy musculature 
positions the condyles in an anterosuperior position (Crawford SD, 1999). One 
study evaluated condylar positions obtained from masticatory muscle contraction 
without influence from occluding teeth. An anterior deprogrammer was used to 
measure condyle position during contraction of masticatory muscles. They found 
that the contraction of masticatory muscles placed the condyles in the same 
position as centric relation, independent of occlusion (McKee JR, 2005). 
In the musculoskeletally stable position, articular surfaces of the TMJ are 
positioned to withstand the greatest amount of force without causing significant 
damage to the temporal bone. Dry skull studies have shown that the anterior and 
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superior roof of the glenoid fossa is sufficiently thick to withstand the heavy 
forces produced by the muscles of mastication. Conversely, the superior and 
posterior roof of the mandibular fossa is composed of comparatively thin bone 
(Moffet BC, 1969).  
2.3.2 Positioning and Reproducibility 
 
         Several studies have concluded that CR is the most accurate and 
reproducible reference point for recording the relationship of the mandible to the 
maxilla (Wood DP, et al., 1988). Several techniques exist on positioning a patient 
into centric relation. Dawson and Okeson recommend the bilateral manual 
manipulation, which has become a common clinical practice among 
prosthodontists and orthodontists. This technique involves manipulating the 
mandible when the patient is in a supine position with the chin lifted. The clinician 
places 4 fingers of each hand on the lower border of the mandible, with the 
thumbs resting on the symphysis of the chin. Firm but gentle force is placed to 
guide the mandible in a downward and backward direction, with the goal of 
positioning the condyles in their most superior-anterior position against the 
posterior slopes of the articular eminence. To ensure the condyles have not 
translated, it is recommended to disclude the anterior teeth approximately 10mm. 
The bilateral manipulation technique is shown in figure 2.3 (Okeson JP, 2015). 
           Tarantola performed a study to measure the reproducibility of centric 
relation using the bimanual manipulation technique. Dentists were randomly 
assigned to one of five patients and asked to position the patient in centric 
relation. The final position was recorded using the same wax recording 
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technique, and were analyzed using the Denar Centri-Check marking system. 
They found that the maximum variation of condylar positions were 0.1mm 
(Tarantola GJ, et al., 1997). 
2.3.3 Centric Relation-Centric Occlusion Discrepancy 
 
         Centric occlusion (CO) and maximum intercuspation (MI) are often used 
synonymously, and represents the most closed position that the mandible 
assumes when teeth cusps are fully interposed with the cusps of the opposing 
arch. Centric occlusion defines the vertical dimension of occlusion in both the 
anteroposterior (AP) and vertical planes of space. 
         In an optimal functional occlusion, there is even and simultaneous contact 
of all posterior teeth, with light contact of anterior teeth, and condyles placed in 
centric relation. However, it is widely accepted that a large portion of the 
population shows a discrepancy between the centric occlusal position and the 
mandible in centric relation. An epidemiological study revealed nearly 86% of the 
323 adult patients evaluated presented with a minor mandibular displacement 
from CR to CO. All of these patients demonstrated a shift in the vertical plane, 
nearly all exhibited an anterior component, and a third showed lateral movement. 
(Rieder CE, 1978).  In a landmark study by Posselt in the early 1950’s, he 
indicated that the average distance between the retruded CR position and CO 
was 1.25mm. This discrepancy remained constant after orthodontic treatment, 
and was smaller in children (Posselt U, 1952). However, the normal ranges for 
occlusal and condylar displacement in an asymptomatic population remains a 
controversial topic. 
18 
 
In Posselt’s envelope of motion, a centric slide is described by the first CR 
tooth contact to maximum intercuspation. When CR and CO coincide, there is no 
premature contact and consequently no slide is observed upon maximum 
closure. The direction and magnitude of slide is based upon the presence and 
location of premature contacts, which may also trigger para-functional habits 
such as clenching and bruxism. 
Several different clinical methods have been performed to evaluate 
condylar displacement, including radiographic imaging, centric relation mounting 
with mandibular position indicators, and chair side visualization. Arthrography 
and arthroscopy procedures can be utilized, but are often expensive and invasive 
with questionable value. 
Movement of the condyles from CR to CO is most commonly in a 
posteroinferior direction, resulting in an anterior displacement of the mandiblular 
dentition. In addition, when condyles are displaced from CR to CO, overjet is 
often decreased and overbite is increased. Cordray found significant increased 
overjet, decreased overbite, midline differences, and Angle classification 
changes in patients with condyles fully seated when compared to CO (Cordray 
FE, 2006). These occlusal changes can significantly alter orthodontic diagnosis 
and treatment plans.   
Several studies have evaluated condylar positions in CR vs CO and 
attempted to make correlations with certain population groups. A three-
dimensional study was performed to compare the condylar position between CR 
and CO for 107 patients before orthodontic treatment. A mandibular position 
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indicator was used to ensure accurate CR mounting. Data from the MPI was 
used to examine the frequency, direction, and magnitude of CO-CR difference. 
This data was also correlated to the patients Angle classification, ANB angular 
measurement, age, or gender. The amount of CR-CO difference was identical for 
right and left sides, and found a mean displacement of 0.84 mm inferiorly, 0.61 
mm posteriorly, and only 0.27 mm laterally. It found no correlation with the 
patient’s age, ANB angle, gender, or Angle classification. Therefore, these 
variables cannot be used to predict the magnitude, frequency and direction of 
CO-CR changes at the condylar level (Utt TW, et al., 1995).  A subsequent study 
confirmed no correlation between CO-CR shift and Angle’s classification (Afzal A, 
et al., 1995).    
In a prospective study of 596 asymptomatic patients, Cordray found that 
94.1% had a premature contact on a posterior tooth with changes in condylar 
position from CR to CO in an inferior (98.1%) and distal or posterior (65.8%) 
direction when the teeth were brought into CO. Also, the mean magnitude of the 
vertical component between CR and CO was more than two times greater than 
the horizontal component (Cordray FE, 2006). These results support previous 
findings in terms of the direction and magnitude of condylar displacement from 
CR to CO. 
2.3.4 Splint Therapy 
  
  Splint therapy can be defined as the “art and science of establishing 
neuromuscular harmony in the masticatory system by creating a mechanical 
disadvantage for parafunctional forces with removable appliances” (Dylina TJ, 
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2001). Occlusal splints simulate an ideal functional occlusion and are used to 
diagnose and treat various masticatory disorders, including bruxism and other 
parafunctional habits, fatigued masticatory muscles, myofascial pain, and 
temporomandibular joint disorder (TMD). Clinicians often “test” the response to 
splint therapy before considering definitive treatment while also ensuring a stable 
seated condylar position for proper occlusal diagnosis.  
 Various types of appliances can be fabricated to perform different 
functions depending on the needs of the patient. Most occlusal splints are 
fabricated with hard or soft acrylic and adjusted to fit on either the maxillary or 
mandibular dentition. Stabilization splints, also known as the Michigan splint or 
centric relation appliance, are commonly used for TMJ dysfunction and 
myofascial pain. It is constructed to achieve ideal functional occlusion. The 
maxillary anterior guided orthotic (MAGO) is a common occlusal splint that is 
horseshoe shaped and fits onto the maxillary dentition. When properly adjusted it 
simulates an ideal functional occlusion with even contact on all posterior teeth in 
CR and very little contact of anterior teeth. Adjustments are also made on lateral 
and protrusive excursive movements. The mandibular splint, or Tanner splint, is 
very similar to MAGO but instead is placed onto the mandibular dentition.  
Several studies have confirmed the clinical effectiveness to reduce 
myofascial pain in patients with stabilization splints.  Carraro performed a 
prospective study of 170 TMD patients treated with full coverage splints on either 
the maxillary or mandibular dental arches. They found that eighty-two percent of 
subjects responded favorably with significant reduction of TMJ pain and muscle 
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pain and also improved dysfunction (Carraro and Caffesse, 1978). A similar 
study was performed by Okeson in which pain responses of individual muscles 
and TMJ were scored before and after splint therapy. Eight-five percent of the 33 
subjects showed a decrease in observable pain scores (Okeson, et al., 1982). In 
a recent systematic review of stabilization splint therapy for the treatment of 
temporomandibular myofascial pain, it was concluded that there is insufficient 
evidence either for or against the use of stabilization splint therapy over other 
active interventions and recommended well-conducted RCT’s to clarify the 
clinical effectiveness. However, it did appear that stabilization splint therapy was 
effective at reducing pain severity at rest and on palpation when compared to no 
treatment (Al-Ani Z, et al., 2005).   
 Along with changes in the occlusion and muscle function, splints can also 
affect the temporomandibular joint. Repositioning splints act in the reverse of 
stabilization splints by moving condyles down the eminence and out of the 
glenoid fossa. This movement can be beneficial to patients suffering from internal 
disc derangement. Repositioning the condyles down the eminence relieves 
pressure on the retrodiscal tissue and facilitates soft tissue healing and resolution 
of effusion. Anterior repositioning splints are typically used for short periods of 
time and often concurrently with anti-inflammatory medication (Okeson JP, 
2003).  
 Splint therapy has also proven to be an effective technique for 
deprogramming the neuromusculature in patients with significant CR-CO 
condylar discrepancies. The proprioception of masticatory muscles, tendons, 
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periodontal ligaments and the TMJ all influence the muscle programming of 
centric occlusion. When this occlusion does not coincide with centric relation, 
occlusal interferences can alter the arc of closure in an attempt to protect the 
interfering teeth from absorbing the entire masticatory force. Deconditioning 
these neuromuscular patterns to the ideal functional occlusion can be clinically 
challenging. Studies have shown splint therapy to be reliable in deprogramming 
neuromuscular habits through full-time wear of stabilization splints in CR, 
particularly when signs and symptoms of TMD are present (Clark GT, 1984).  
2.4 Centric Relation and Airway 
 
Numerous authors, clinicians and educators agree that a fully seated 
condylar position in centric relation is an essential component of a stable and 
functional occlusion. However, no studies have investigated what effect seated 
condyles in centric relation have on the posterior pharyngeal airway space.  
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Figure 2.1 Mandibular advancement device (Naomi T, 2009).  
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Figure 2.2 Directional forces of temporalis, masseter, and medial pterygoid muscles 
seat the condyles in a superior-anterior position in the fossae (Okeson JP, 2015).   
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Figure 2.3 Representation of the bilateral manual manipulation technique to position the 
mandibular condyles in centric relation (Okeson JP, 2015). 
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CHAPTER 3: STUDY AIMS 
 
3.1. Statement of the Problem 
 
Currently the relationship between the volume of the posterior pharyngeal 
space and mandibular position is unknown. The effect that seating mandibular 
condyles in centric relation on the volumetric and cross-sectional area of the 
posterior pharyngeal airway is yet to be investigated.  
3.2. Null Hypothesis 
 
 There is no difference in total posterior pharyngeal airway volume, 
nasopharynx volume and oropharynx volume before and after seating 
mandibular condyles in centric relation.   
3.3. Specific aims of current study 
 
 Compare total posterior pharyngeal volume before and after splint 
therapy.  
 Compare nasopharynx & oropharynx volume before and after splint 
therapy 
 Compare cross-sectional area at the level of the posterior nasal spine, 
cervical vertebrae 2, and cervical vertebrae 3 before and after splint 
therapy.  
 Compare the cross-sectional area and location of the minimum cross-
sectional area before and after splint therapy.   
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CHAPTER 4: MATERIALS & METHODS 
  
4.1 Splint fabrication 
 
 All subjects were patients at a private orthodontic office (Dr. Mary Burns, 
New Hope, PA) and presented with signs and symptoms of upper airway 
obstruction with centric relation-centric occlusion discrepancies. Each subject 
was placed into centric relation using the bilateral manual manipulation 
technique. Wax registration material and facebow were used to record the inter 
jaw position, which was transferred to an articulator. Stone models were used to 
fabricate a maxillary anterior guided orthotic (MAGO) appliance (figure 4.24). The 
stabilization splint was then placed on the maxillary dentition and adjusted until 
the condyles were fully seated in centric relation. All subjects were asked to wear 
the appliance twenty-four hours a day.  
4.2 Image acquisition 
 
         All radiographic scans analyzed in this study were taken with Kodak CBCT 
machine (Carestream Health, Toronto Canada) with a field view of 18.4 cm x 
20.6 cm and a voxel size of 0.3 mm. All scans were completed at the private 
office of Dr. Mary Burns in New Hope, Pennsylvania. 
        Initial scans were taken on all subjects in maximum intercuspation in the 
upright position with Frankfurt horizontal parallel to the floor. Post treatment 
scans were taken in centric relation with the maxillary anterior guided orthotic 
placed on the maxillary arch. The average time between pre and post scans was 
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7 months and 8 days. A total of 31 subjects pre- and post-treatment CBCT scans 
were evaluated (13 male and 18 female). Although not all subjects underwent a 
comprehensive sleep study for diagnosis of obstructive sleep apnea, all 
presented with signs and symptoms of OSA. Many of the subjects received 
orthodontic treatment following MAGO therapy. Both the CBCT scans and 
orthodontic therapy were performed by Dr. Mary Burns. The mean subject age at 
the time of the post-MAGO scan was 45.8 years, and ranged from 19 to 64.4.  
         The study aims and protocols were reviewed and approval was obtained 
from the UNMC Institutional Review Board prior to commencement of the study 
(IRB approval # 681-14-EP). Informed consent was obtained from all subjects. All 
scans were acquired in DICOM file format and exported for interpretation. The 
interpretation of all CBCT images was performed on Anatomage Invivo5 viewing 
software version 2.1 (Anatomage, San Jose, California) licensed to the University 
of Nebraska Medical Center College of Dentistry. 
4.3 Volumetric Airway Analysis 
 
Airway volumetric analysis was performed using airway analysis tool in 
Anatomage Invivo5 viewing software. All scans were oriented in the sagittal view 
using the incisive canal and the 2nd cervical vertebrae (CV2). In preparation for 
upper airway analysis, several anatomic planes and points were determined to 
measure different regions of the airway. A plane between posterior nasal spine 
(PNS) and sella formed the superior limit, and a plane passing through the 
inferior border of the 3rd cervical vertebrae (CV3) formed the inferior limit. Total 
volume was defined as the sum of nasopharynx and oropharynx, and calculated 
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by measuring space between a horizontal plane at the inferior border of CV3 and 
vertical plane connecting sella turcica and PNS. Nasopharynx volume was 
defined as the area between a plane parallel with Frankfurt horizontal at PNS 
and a plane passing through PNS and sella. The oropharynx volume was defined 
by the area between a plane parallel with Frankfurt horizontal at PNS and a 
plane parallel with Frankfurt horizontal at the inferior border of CV3.  
Clipping and sculpting tools were used to isolate total volume and 
oropharynx volume (figures 4.1-4.2, 4.7-4.8). Clipping was initially done in gray 
scale in order to better visualize the skeletal reference points. The sculpting tool 
was then used to remove unnecessary soft tissue and skeletal structures from 
both right and left sagittal views of the airway. The lateral walls of the airway 
were then sculpted in the frontal view (figures 4.3-4.5, 4.9-4.11). The volume 
measurement tool was used to calculate the volume in cubic centimeters (figures 
4.6, 4.12). The nasopharynx volume was calculated by subtracting the total 
volume by oropharynx volume. All scans were measured with a lower threshold 
value of -1000 and upper value at -603 Hounsfield units (HU). These thresholds 
values were adapted from a previous study by Hart, et al, 2015. Pre- and post-
treatment scans were recorded and compared for changes in airway volume for 
all three regions. A positive number represents an increase in volume. All 
volumetric analyses were performed by 1 examiner (JS).  
4.4 Cross Sectional Area Analysis 
 
 Cross-sectional area measurements were taken at the inferior border of 
each volumetric region with the airway analysis tool in Anatomage Invivo5 
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viewing software. Each scan was oriented in the sagittal view using the incisive 
canal and CV2. Measurements were taken at horizontal plane parallel with 
Frankfurt horizontal at PNS, inferior border of CV2 and the inferior border of CV3. 
Using the area measurement tool, the airway border was traced and then 
calculated in millimeter squared (figures 4.13-4.21). Pre- and post-treatment 
scans were recorded and compared at all three airway levels.   
4.5 Minimum Cross-Sectional Area Analysis 
 
 The minimum cross-sectional area is defined as the most constricted 
portion of the airway. The volume rendering tool was used to determine the 
minimum cross-sectional area along the total airway, bordered superiorly with a 
plane between PNS and sella, and inferiorly by a plane passing through the 
inferior border of CV3 and measured in millimeter squared (figures 4.22-4.23). 
The location of the minimum cross-sectional area was observed and recorded in 
relation to the superior, middle and inferior thirds of the bodies of CV2 and CV3 
and the occlusal plane. Pre- and post-treatment minimum cross-sectional areas 
and locations were compared at all three regions.  
4.6 Method Error 
  
 Intraobserver reliability tests were performed to investigate the potential 
error in identifying skeletal landmark and airway volumetric and cross-sectional 
area measurements. After one month of initial tracings, ten subjects were 
randomly selected (5 male and 5 female) and measured a second time by the 
same examiner (JS). The differences for all variables recorded in first and 
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second measurement periods were compared for all 10 subjects. Pearson 
correlation coefficient was calculated for each variable.   
4.6 Statistical Analysis 
 
 Means for all volumetric and cross-sectional measurements were 
determined for pre-treatment and post-treatment scans. A paired two-sample T-
test was performed using SPSS (version 16.0, IBM, Armonk, NY) to determine 
the significance of change in volume, cross-sectional area, and minimal cross-
sectional area for all three airway regions. F-test was performed to determine the 
variability for gender and age with all measurements.  
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Figure 4.1. Polygon sculpture tool used to isolate total volume. Superior boundary 
of total volume defined by plane connecting posterior nasal spine (PNS) and sella (upper 
yellow line). Inferior boundary represented by horizontal line bisecting inferior border of 
CV3 (lower yellow line).   
 
33 
 
 
Figure 4.2. Total volume region of airway after initial clipping. Inverse color scale 
was used to better visualize the airway. Freehand sculpture tool was then used to draw 
the border of airway, removing unnecessary soft tissue and skeletal structures from both 
right and left sides.  
 
Figure 4.3. Sagittal view of total volume after freehand sculpture.  
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Figure 4.4. Frontal view of total volume. Freehand sculpture tool was used to outline 
the border of airway, removing unnecessary soft tissue and skeletal structures from the 
lateral boundaries.  
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Figure 4.5. Isolated frontal view of total volume airway.  
 
 
 
Figure 4.6. Volume rendering of isolated total volume airway with density of -603 
HU. Airway volume was calculated in cubic centimeters. 
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Figure 4.7. Polygon sculpture tool used to isolate oropharynx volume. Superior 
boundary of oropharynx defined by plane parallel with Frankfurt horizontal at PNS (upper 
yellow line). Inferior boundary defined by horizontal line parallel with Frankfurt horizontal 
bisecting inferior border of CV3 (lower yellow line).  
 
 
 
 
Figure 4.8. Oropharynx region of airway after initial clipping. Inverse color scale 
was used to better visualize the airway. Freehand sculpture tool was then used to draw 
the border of airway, removing unnecessary soft tissue and skeletal structures from both 
right and left sides.  
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Figure 4.9. Sagittal view of oropharynx after freehand sculpture.  
 
 
 
 
Figure 4.10. Frontal view of oropharynx. Freehand sculpture tool was used to outline 
the border of airway, removing unnecessary soft tissue and skeletal structures from the 
lateral boundaries.  
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Figure 4.11. Frontal view of oropharynx after freehand sculpture.  
 
 
Figure 4.12. Volume rendering of the isolated oropharynx airway with density of -
603 HU. Airway volume was calculated in cubic centimeters.   
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Figure 4.13. Images were oriented in the sagittal view using the incisive canal and 
CV2.  Cross-sectional area measured at the level of PNS (orange horizontal line).  
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Figure 4.14. Transverse view of cross-sectional area at PNS.  
 
 
 
 
Figure 4.15. Area measurement tool used to trace airway border at PNS. Cross-
sectional area was measured in millimeters squared.  
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Figure 4.16. Images were oriented in the sagittal view using the incisive canal and 
CV2.  Cross-sectional area measured at the level of CV2 (orange horizontal line).  
 
 
Figure 4.17. Transverse view of cross-sectional area at CV2.  
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Figure 4.18. Area measurement tool used to trace airway border at CV2. Cross-
sectional area was measured in millimeters squared.  
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Figure 4.19. Images were oriented in the sagittal view using the incisive canal and 
CV2.  Cross-sectional area measured at the level of CV3 (orange horizontal line).  
 
Figure 4.20. Transverse view of cross-sectional area at CV3.  
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Figure 4.21. Area measurement tool used to trace airway border at CV3. Cross-
sectional area was measured in millimeters squared.  
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Figure 4.22. Images were oriented in the sagittal view using the incisive canal and 
CV2. Volume rendering tool used to determine the minimum cross-sectional area of total 
airway.  
 
46 
 
 
Figure 4.23. Minimum cross-sectional area identified and recorded in millimeter 
squared. The location of the minimum CSA was observed and recorded in relation to 
the superior, middle, and inferior thirds of the bodies of CV2 and CV3.    
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Figure 4.24. Maxillary anterior guided orthotic (MAGO). Courtesy of Dr. Mary Burns, 
New Hope PA.  
 
 
 
 
 
Figure 4.24. MAGO appliance. Courtesy of Dr. Mary  Burns, New Hope, PA.  
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CHAPTER 5: RESULTS 
 
5.1 Total Volume Measurements 
 
 The average pre- and post-treatment measurements for total volume, 
nasopharynx, and oropharynx on all subjects are shown in figure 5.1. The mean 
total volume comparison between pre- and post-treatment measurements are 
shown in figure 5.2. Error bars represent the upper and lower 95% confidence 
limits of each measurement. A summary of the paired two-sample T-test is 
shown in appendix B. P-value for all volumetric measurements was set at <0.05. 
Thirteen out of the 31 subjects (42%) showed a decrease in total volume, while 
18 out of 31 (58%) exhibited an increase in total volume (p=0.53).  
5.2 Regional Volume Measurements 
 
  The average pre- and post-treatment regional volume measurements at 
nasopharynx and oropharynx are shown in figures 5.3 and 5.4 respectively. All 
error bars represent the upper and lower 95% confidence limits of each 
measurement. A summary of the paired T-test for nasopharynx and oropharynx 
measurements are shown in appendix A.  
5.3 Minimum Cross-Sectional Area Measurement 
 
          The mean minimum cross-sectional area measurements for all subjects 
pre- and post-treatment are shown in figure 5.5. Error bars represent the upper 
and lower 95% confidence limits of each measurement. P-value for all cross-
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sectional measurements was set at <0.05. Similarly to total volume 
measurement, 13 out of the 31 subjects (42%) showed a decreased minimum 
cross-sectional area, while 18 out of 31 (58%) exhibited larger minimum cross-
sectional areas. 
5.4 Cross-Sectional Area Measurements 
 
 The average pre- and post-cross-sectional area measurements for all 
subjects at posterior nasal spine, second cervical vertebrae, and third cervical 
vertebrae are shown in figures 5.6, 5.7, and 5.8 respectively.  All error bars 
represent the upper and lower 95% confidence limits of each measurement. The 
paired two-sample T-test results for cross sectional measurements at posterior 
nasal spine, second cervical vertebrae, and third cervical vertebrae are shown 
are shown in appendix A.  Figure 5.9 shows the average pre- and post-treatment 
cross-sectional area measurements at PNS, CV2, CV3, and minimum cross-
sectional area.  
5.5. Volumetric and Cross-Sectional Mean Differences 
 
 The mean differences between pre- and post-treatment volumetric and 
cross-sectional area measurements are found in figures 5.10 and 5.11, 
respectively. The mean percent differences for all volumetric and cross-sectional 
area measurements are shown in figures 5.12 and 5.13, respectively. All 
standard error bars represent the upper and lower 95% confidence limits of each 
measurement.  
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5.6. Location of Minimum Cross-Sectional Area  
  
 The location of the minimum cross-sectional area was recorded in relation 
to the superior, middle and inferior thirds of the bodies of CV2 and CV3 and the 
occlusal plane. These findings are represented in figure 5.14.   
5.7 Airway Changes All Subjects 
 
 Pre- and post-treatment mean volumetric and cross-sectional area 
measurements, and mean differences for each measurement are summarized in 
table 5.1 for all subjects. Standard deviation and p-values with associated 
significance for each measurement are shown.   
5.8 Airway Changes Male vs Female 
 
Table 5.2 summarizes airway changes for female subjects, and table 5.3 
summarizes airway changes in male subjects with associated standard deviation, 
p-values, and mean differences. F-test was performed to determine the variability 
for gender with all measurements. No significant differences were found between 
male and female with all volumetric and cross-sectional area measurements.  
5.9 Method Error 
 
 The repeatability of each value was tested by calculating the Pearson 
correlation coefficient on initial and final measurements one month later on 10 
randomly chosen subjects. The average correlation coefficient was 0.986, 
ranging from 0.960 to 0.998, as shown in table 5.4.  
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Figure 5.1. Pre- and post-treatment mean total volume, nasopharynx volume, and 
oropharynx volume.  
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Figure 5.2. Pre- and post-treatment mean total volume (cm3). 
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Figure 5.3. Pre- and post-treatment mean nasopharynx volume (cm3). 
 
 
Figure 5.4. Pre- and post-treatment mean oropharynx volume (cm3).  
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Figure 5.5. Pre- and post-treatment mean minimum cross-sectional area (mm2).  
 
 
Figure 5.6. Pre- and post-treatment mean cross-sectional area at PNS (mm2).  
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Figure 5.7. Pre- and post-treatment mean cross-sectional area at CV2 (mm2).  
 
 
Figure 5.8. Pre- and post-treatment mean cross-sectional area at CV3 (mm2).  
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Figure 5.9. Pre- and post-treatment mean cross-sectional area at PNS, CV2, CV3, and 
minimum cross-sectional area.  
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Figure 5.10. Pre- and post-treatment mean volumetric differences.  
 
Figure 5.11. Pre- and post-treatment mean cross-sectional area mean differences 
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Figure 5.12 Pre- and post-treatment mean volume percent differences. 
 
 
Figure 5.13. Pre- and post-treatment mean cross-sectional area percent differences.   
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Figure 5.14. Location of minimum cross-sectional area pre- and post-treatment. 
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Table 5.1. Airway changes for all subjects (n=31). 
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Table 5.2. Airway changes for female subjects (n=18). 
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Table 5.3. Airway changes for male subjects (n=13) 
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Table 5.4. Pearson correlation coefficient’s for initial and final measurements on 10 
randomly chosen subjects. Average correlation coefficient was 0.986, ranging from 
0.960 to 0.998. 
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CHAPTER 6: DISCUSSION 
 
 
6.1. Method of Error 
 
 
 Pearson reliability coefficient was found to determine the repeatability 
made for all measured variables. After one month of initial tracings, ten subjects 
were randomly chosen to be re-measured (5 male and 5 female). The second 
measurements were performed by the same examiner (JS). The average 
correlation coefficient was 0.986, ranging from 0.960 to 0.998. This high 
correlation coefficient indicates a strong positive relationship between the two 
measurements, ensuring accurate reliability for all measured outcomes.  
6.2. Total Volume Measurements  
 
 
 Total volume was defined as the sum of nasopharynx and oropharynx, 
and calculated by measuring space between a horizontal plane at the inferior 
border of CV3 and vertical plane connecting sella turcica. Pre-treatment total 
mean volume was 11.92 cm3 and post-treatment total mean volume was 12.45 
cm3, a mean difference of 0.53 cm3. Thirteen out of thirty-one subjects (42%) 
showed a decrease in total volume, whereas eighteen out of thirty-one (58%) 
exhibited an increase in total volume. Although the total mean volume was 
greater after treatment, this increase was not statistically significant (p=0.22).  
The methodology of the present study did not measure the biological significance 
of the increase in total mean volume. Further studies are needed to assess the 
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clinical efficacy of splint therapy to reduce severity and complications that arise 
from OSA.     
6.3. Regional Volumetric Measurements 
 
 Nasopharynx volume was defined as the area between a plane parallel 
with Frankfurt horizontal at PNS and a plane passing through PNS and sella. 
Pre-treatment nasopharynx mean volume was 2.27 cm3 and post-treatment 
mean volume was 2.74 cm3, a mean difference of 0.47 cm3. This mean increase 
was not statistically significant (p=0.13). Oropharynx volume was defined by the 
area between a plane parallel with Frankfurt horizontal at PNS and a plane 
parallel with Frankfurt horizontal at the inferior border of CV3. Pre-treatment 
oropharynx mean volume was 9.66 cm3 and post-treatment mean was 9.71 cm3, 
a mean difference of 0.05 cm3. The mean increase was not statistically significant 
(p=0.47).  
6.4. Cross-sectional Area Measurements 
 
 Cross-sectional area measurements were taken at a horizontal plane 
parallel with Frankfurt horizontal at PNS, inferior border of CV2 and the inferior 
border of CV3. Pre-treatment means for cross-sectional area measurements at 
PNS, CV2, and CV3 were 466.1, 202.3, and 226.3 mm2, respectively.  Post-
treatment mean measurements at PNS, CV2 and CV3 were 474.9, 185.4 and 
232.1 mm2, respectively.  The mean differences between these pre-and post- 
measurements for PNS, CV2, and CV3 are 8.77, -16.89, and 5.82 mm2. These 
mean differences were not statistically significant (p=0.31, p=0.13, and p=0.34).  
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6.5. Minimum Cross-Sectional Area Measurements  
 
 The minimum cross-sectional area is defined as the most constricted 
portion of the airway. Pre-treatment minimum cross-sectional area mean was 
115.6 mm2 and post-treatment mean was 105.5 mm2. The mean difference was 
a -10.1 mm2, though this difference was not statistically significant (p=0.23). 
6.6. Percent Differences 
 
 The percent difference of pre- and post-treatment measurements was 
calculated for volumetric, cross-sectional area, and minimum cross-sectional 
area dimensions. The greatest percent increase was found in the nasopharynx at 
34%. Both total volume and oropharynx also revealed a positive percent 
increase. Total volume increased 10.1% and the oropharynx volume increased 
5.9%.  These data are consistent with the mean volumetric differences previously 
discussed.  
 The mean cross-sectional area percentage difference at PNS, CV3, and 
minimum cross-sectional area all increased very slightly. PNS increased 0.03%, 
CV3 increased 0.08% and the minimum CSA increased 0.04%.   
6.7. Location of Cross-sectional Area 
 
 The location of the minimum cross-sectional area was recorded in 
reference to the superior, middle, and inferior thirds of the bodies of CV2 and 
CV3, and also the occlusal plane.  Differences between pre- and post-treatment 
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minimum cross-sectional area locations were found on fourteen of the thirty-one 
patients (45%). One-half of these subjects showed minimum cross-sectional area 
relocation inferior to the pre-treatment recording, while the other half showed a 
more superior relocation.  
 Twenty-six of the thirty-one subjects (84%) displayed a minimum cross-
sectional area located at either the superior, middle, or inferior third of the CV2 
body. In addition, the minimum cross-sectional area was found to be inferior to 
the occlusal plane in twenty-eight of the thirty-one subjects (90%). This finding is 
consistent with Ogawa et al., who found the location of the minimum cross-
sectional area in patients with OSA was below the occlusal plane in more than 
70% of the subjects (Ogawa T, et al., 2007). This indicates that our image 
acquisition and radiographic interpretation methodology were accurate. Also, 
since 84% of the subjects displayed a minimum cross-sectional area at the level 
of CV2 body, the mean decrease in minimum cross-sectional area is consistent 
with our previous finding of a decrease in cross-sectional area at CV2.  
6.8 Airway Changes Male vs Female  
 
 No significant differences were found between male and female with all 
volumetric and cross-sectional area measurements. This finding agrees with 
previous studies that found no correlation with gender after examining the 
frequency, direction and magnitude of condylar changes in CR vs CO (Utt TW, et 
al., 1995).   
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6.9 Centric Relation and Airway 
 
 Several studies have confirmed that a fully seated condylar position in 
centric relation is an essential component of a stable and functional occlusion, 
and is a desirable physiologic goal for orthodontic correction.  Okeson describes 
it as the most orthopedically and musculoskeletally stable position of the 
mandible (Okeson JP, 2015).  Additional studies have shown that a healthy 
masticatory musculature positions in the condyles in centric relation, independent 
of occlusion (Crawford SD, 1999).  Presently, there is no published literature that 
documents the relationship between centric relation and its influence on the 
posterior pharyngeal airway.  
 Stabilization splint therapy has been shown to accurately seat the 
condyles in centric relation while deprogramming the neuromusculature in 
patients with significant CR-CO condylar discrepancies.  This therapy has proven 
effective in diagnosing and treating myofascial pain, TMD, and various 
masticatory disorders.  Several studies have documented the movement of the 
condyles from CR to CO, in both magnitude and direction. Cordray discovered 
that the most common direction of condylar movement was in a posterior and 
inferior direction, resulting in an anterior displacement of the mandible (Cordray 
FE, 2006). This movement resulted in decreased overjet and increased overbite. 
In addition, the mean difference in condylar position between CR and CO was 
almost double in the vertical plane (1.8 mm) compared to the horizontal (0.86 
mm) and transverse plane (0.26 mm). This increase in vertical dimension may 
elucidate the overall increase in mean total airway volume in the present study.  
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6.10. Study Limitations  
 
  All subjects evaluated in this study presented with signs and symptoms of 
upper airway obstruction with significant CR-CO discrepancies. Not all subjects 
performed a sleep study test to confirm the presence and/or severity of OSA. In 
addition, the magnitude and direction of discrepancy was not available for each 
subject. Consequently, it was not possible to correlate the magnitude and 
direction of discrepancy with the final volumetric and cross-sectional area results.  
 All subjects were patients at a private orthodontic office, and may not 
accurately represent a sample of the general population. In addition, subjects 
presented with differing medical histories, ethnicities, and anatomical variations.  
 Although CBCT has been proven to be an effective tool in evaluating 
airway parameters, it is a static evaluation of a dynamic structure. All scans were 
taken in an upright position, which is not representative of the airway in the 
supine position during sleep. CBCT studies have shown that the airway’s 
volumetric and cross-sectional area dimensions are significantly smaller in 
patients in supine position compared with an upright position (Camacho M, et al., 
2014). In addition, positional and posture discrepancies between pre- and post-
treatment scans may exist.  
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CHAPTER 7: CONCLUSION 
 
Positioning the mandibular condyles in centric relation does influence 
posterior pharyngeal airway volume and cross-sectional area; however, the 
dimensional changes are not statistically significant. Post-treatment mean total 
volume, oropharynx volume, and nasopharynx volume increased. Mean cross-
sectional area at PNS and CV3 increased, while mean cross-sectional area at 
CV2 and minimum cross-sectional area decreased. Twenty-six of the thirty-one 
subjects (84%) displayed a minimum cross-sectional area located at body of 
CV2. The minimum cross-sectional area was found to be inferior to the occlusal 
plane in twenty-eight of the thirty-one subjects (90%).  Further studies are 
needed to assess the clinical efficacy of splint therapy to reduce severity and 
complications that arise from OSA.    
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Appendix A: Experimental Data – Mean Differences 
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TV Pre TV Post Difference
13.419 12.509 -0.91
16.951 25.491 8.54
14.128 13.09 -1.038
5.197 10.402 5.205
5.697 4.47 -1.227
18.947 7.683 -11.264 Mean Difference 0.527064516
9.39 8.225 -1.165 Standard Dev of Difference 3.81815692
4.123 6.79 2.667 Standard of Error Difference 0.685761227
10.196 7.713 -2.483 T alpha half 95% CI 2.0422
8.043 10.84 2.797 P-value 0.448149
15.431 22.526 7.095
10.952 17.141 6.189
12.064 11.929 -0.135
11.875 14.27 2.395
17.477 17.984 0.507
18.284 17.31 -0.974
11.552 11.259 -0.293
12.015 13.683 1.668
9.394 10.455 1.061
10.101 11.314 1.213
5.841 6.321 0.48
11.199 14.371 3.172
9.498 7.912 -1.586
11.374 12.237 0.863
28.649 26.279 -2.37
11.335 7.393 -3.942
4.93 8.296 3.366
15.063 8.64 -6.423
11.616 11.933 0.317
7.941 10.058 2.117
17.039 17.536 0.497
Appendix A: Experimental Data – Total Volume 
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NV Pre NV Post Difference
5.046 4.445 1.274
1.904 1.427 3.042
3.238 3.601 -0.514
0.217 1.799 -0.207 Mean Difference 0.47571
0.861 0.15 -1.116 Standard Dev of Difference 1.32207
1.471 3.091 -0.098 Standard of Error Difference 0.23745
1.875 2.07 0.925 T alpha half 95% CI 2.0422
0.987 2.287 0.74 P-value 0.05424
3.322 2.52 0.487
1.225 2.78 -0.01
2.791 2.349 0.49
3.202 8.054 2.531
1.53 1.183 -0.892
0.865
1.784 3.058 -0.761
1.177 4.219 -0.913
2.956 2.442 0.875
0.441 0.234 -0.058
3.553 2.437 -0.601
3.486 3.388 -0.477
1.227 2.152 0.363
1.584 2.324 1.582
3.457 3.944 -0.711
1.278 1.268 1.62
3.368 3.858 0.195
4.088 6.619 1.3
2.984 2.092 -0.802
0.337 1.202 1.555
3.185 2.424 -0.442
2.719 1.806 4.852
2.463 3.338 -0.347
2.542 2.484 -0.058
Appendix A: Experimental Data – Nasopharynx 
Volume 
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OV Pre OV Post Difference
8.373 8.064 -0.309
15.047 24.064 9.017
10.89 9.489 -1.401
4.98 8.603 3.623
4.836 4.32 -0.516 Mean Difference 0.04975
17.476 4.592 -12.884 Standard Dev of Difference 3.73034
7.515 6.155 -1.36 Standard of Error Difference 0.66999
3.136 4.503 1.367 T alpha half 95% CI 2.04522
6.874 5.193 -1.681 P-value 0.9289
6.818 8.06 1.242
12.64 20.177 7.537
7.75 9.087 1.337
10.534 10.746 0.212
0
10.091 11.212 1.121
16.3 13.765 -2.535
15.328 14.868 -0.46
11.111 11.025 -0.086
8.462 11.246 2.784
5.908 7.067 1.159
8.874 9.162 0.288
4.257 3.997 -0.26
7.742 10.427 2.685
8.22 6.644 -1.576
8.006 8.379 0.373
24.561 19.66 -4.901
8.351 5.301 -3.05
4.593 7.094 2.501
11.878 6.216 -5.662
8.897 10.127 1.23
5.478 6.72 1.242
14.497 15.052 0.555
Appendix A: Experimental Data – Oropharynx 
Volume 
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MA Pre MA Post Difference
122.4 58 -64.4
239.9 284.6 44.7
157.5 140.2 -17.3
74.2 75.3 1.1
113.27 39.4 -73.87
162.4 91.9 -70.5 Mean Difference -9.78344
33.8 55.7 21.9 Standard Dev of Difference 45.1376
46 55.4 9.4 Standard of Error Difference 8.10695
128.9 69.4 -59.5 T alpha half 95% CI 2.0422
135.3 153.1 17.8 P-value 0.22958
162.2 220.5 58.3
67.1 42.4 -24.7
161.7 152.3 -9.4
0
99.1 130 30.9
218.4 236.5 18.1
99.5 109.4 9.9
70.9 83.9 13
67.3 83.1 15.8
78.5 111.1 32.6
63 67.5 4.5
22.5 36.7 14.2
60 110.8 50.8
75.4 52.9 -22.5
60.5 69.7 9.2
368.5 280.1 -88.4
85.5 36.2 -49.3
17 39.2 22.2
147.1 63.8 -83.3
105.6 113.7 8.1
93.7 91 -2.7
245.6 115.9 -129.7
Appendix A: Experimental Data – Minimum Sectional Area 
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CSA-PNS Pre CSA-PNS Post Difference
449.51 462.6 13.09
386.29 506.53 120.24
491.01 479.54 -11.47
308.93 573.72 264.79
285.11 214.41 -70.7
354.37 378.51 24.14 Mean Difference 8.76484
468.4 428.78 -39.62 Standard Dev of Difference 97.5503
366.44 475.39 108.95 Standard of Error Difference 17.5206
431.91 463.51 31.6 T alpha half 95% CI 2.0422
482.45 455.43 -27.02 P-value 0.62054
403.92 468.51 64.59
732.71 456.49 -276.22
319.5 250.8 -68.7
610.99 668.04 57.05
391.54 435.12 43.58
723.95 531.25 -192.7
280.75 251.01 -29.74
572.09 643.26 71.17
294.8 320.34 25.54
583.94 570.84 -13.1
479.94 418.37 -61.57
558.7 647.89 89.19
355.91 318.47 -37.44
497.62 505.94 8.32
741.48 862.97 121.49
498.61 452.97 -45.64
532.8 506.61 -26.19
428.54 406.46 -22.08
554.72 674.9 120.18
425.12 470.64 45.52
438.1 422.56 -15.54
Appendix A: Experimental Data – Cross-sectional area at PNS 
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CSA-CV2 Pre CSA-CV2 Post Difference
146.98 96.17 -50.81
245.68 451.49 205.81
222.55 212.26 -10.29
108.67 118.81 10.14
188.55 164.77 -23.78
433.97 167.46 -266.51 Mean Difference -16.3666
79.45 85.93 6.48 Standard Dev of Difference 81.4521
125.8 125.51 -0.29 Standard of Error Difference 14.6292
169.48 145.1 -24.38 T alpha half 95% CI 2.0422
228.63 242.23 13.6 P-value 0.26461
458.99 455.72 -3.27
242.44 236.43 -6.01
291.38 316.97 25.59
0
248.5 201.94 -46.56
392.17 226.63 -165.54
108.5 138.78 30.28
281.94 294.09 12.15
88.5 164.88 76.38
90.2 138.1 47.9
212.31 134.51 -77.8
66.28 67.95 1.67
91.38 133 41.62
96.31 94.38 -1.93
75.64 75.81 0.17
375.36 328.43 -46.93
208.41 66.59 -141.82
107.66 106.9 -0.76
252.19 91.41 -160.78
127.53 160.71 33.18
124.26 114.93 -9.33
380.1 388.19 8.09
Appendix A: Experimental Data – Cross-sectional area at CV2 
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CSA-CV3 Pre CSA-CV3 Post Difference
184.14 206.75 22.61
342.31 427.99 85.68
196.91 197.5 0.59
139.23 164.78 25.55
113.27 270.25 156.98
308.73 251.66 -57.07 Mean Difference 5.63531
327.24 283.88 -43.36 Standard Dev of Difference 76.3176
77.83 60.04 -17.79 Standard of Error Difference 13.707
163.37 135.77 -27.6 T alpha half 95% CI 2.0422
115.91 125.21 9.3 P-value 0.67927
189.86 311.24 121.38
176.01 178.69 2.68
204.91 203.85 -1.06
0
255.69 317.01 61.32
210.66 256.3 45.64
447.3 375.71 -71.59
287.65 327.88 40.23
154.8 386.18 231.38
174.2 191.46 17.26
368.02 301.22 -66.8
208.41 234.68 26.27
194.74 154.71 -40.03
125.76 68.53 -57.23
178.11 217.66 39.55
351.73 291.4 -60.33
232.49 131.14 -101.35
230.39 254.7 24.31
342.31 166.58 -175.73
341.87 288.36 -53.51
110.07 141.38 31.31
261.64 273.38 11.74
Appendix A: Experimental Data – Cross-sectional area at CV3 
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Appendix B: t-Test Data  
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  t-Test: Paired Two Sample for Means 
 
     Post TV Pre TV 
Mean 12.4535 11.9265 
Variance 28.9301 25.6714 
Observations 31 31 
Pearson Correlation 0.73431 
 Hypothesized Mean Difference 0 
 df 30 
 t Stat 0.76858 
 P(T<=t) one-tail 0.22407 
 t Critical one-tail 1.69726 
 P(T<=t) two-tail 0.44815 
 t Critical two-tail 2.04227   
t-Test: Paired Two Sample for Means 
 
     Post NV Pre NV 
Mean 2.74339 2.268 
Variance 2.61301 1.451 
Observations 31 31 
Pearson Correlation 0.59475 
 Hypothesized Mean Difference 0 
 df 30 
 t Stat 2.00341 
 P(T<=t) one-tail 0.12712 
 t Critical one-tail 1.69726 
 P(T<=t) two-tail 0.15424 
 t Critical two-tail 2.04227   
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t-Test: Paired Two Sample for Means 
 
     Post OV Pre OV 
Mean 9.71016 9.65881 
Variance 23.8437 21.4293 
Observations 31 31 
Pearson Correlation 0.68336 
 Hypothesized Mean Difference 0 
 df 30 
 t Stat 0.0754 
 P(T<=t) one-tail 0.4702 
 t Critical one-tail 1.69726 
 P(T<=t) two-tail 0.94039 
 t Critical two-tail 2.04227   
t-Test: Paired Two Sample for Means 
 
   
  Post MA Pre MA 
Mean 105.4742 115.6 
Variance 4659.905 5632 
Observations 31 31 
Pearson Correlation 0.799328 
 
Hypothesized Mean Difference 0 
 
df 30 
 
t Stat -1.22643 
 
P(T<=t) one-tail 0.114789 
 
t Critical one-tail 1.697261 
 
P(T<=t) two-tail 0.229577 
 
t Critical two-tail 2.042272   
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t-Test: Paired Two Sample for Means 
 
   
  
Post CSA-
PNS 
Pre CSA-
PNS 
Mean 474.8987097 466.133871 
Variance 18434.29288 16061.59329 
Observations 31 31 
Pearson Correlation 0.725858044 
 Hypothesized Mean 
Difference 0 
 df 30 
 t Stat 0.500260219 
 P(T<=t) one-tail 0.310270984 
 t Critical one-tail 1.697260887 
 P(T<=t) two-tail 0.620541968 
 t Critical two-tail 2.042272456   
 
 
  
t-Test: Paired Two Sample for Means 
 
   
  
Post CSA-
CV2 Pre CSA-CV2 
Mean 185.3574194 202.2519355 
Variance 11676.80099 12929.35443 
Observations 31 31 
Pearson Correlation 0.722698463 
 Hypothesized Mean Difference 0 
 df 30 
 t Stat -1.136831571 
 P(T<=t) one-tail 0.132304042 
 t Critical one-tail 1.697260887 
 P(T<=t) two-tail 0.264608085 
 t Critical two-tail 2.042272456   
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t-Test: Paired Two Sample for Means 
 
   
  
Post CSA-
CV3 
Pre CSA-
CV3 
Mean 232.1255 226.3084 
Variance 8060.732 8289.199 
Observations 31 31 
Pearson Correlation 0.632022 
 Hypothesized Mean Difference 0 
 df 30 
 t Stat 0.417524 
 P(T<=t) one-tail 0.339634 
 t Critical one-tail 1.697261 
 P(T<=t) two-tail 0.679268 
 t Critical two-tail 2.042272   
 
 
 
 
 
 
 
 
